Gaffney P J, Mussett M V
Thromb Haemost. 1983 Oct 31;50(3):645-9.
An international collaborative study involving seven laboratories was undertaken to assess the suitability of a freeze-dried preparation of human plasmin to replace the current International Reference Preparation (IRP) for plasmin. Chromogenic and fibrinolytic assays were used by all participating laboratories to assess the potencies of the Proposed International Reference Preparation (PIRP) and two other freeze-dried plasmins, one of human and one of porcine origin. The data suggest that the PIRP is a more suitable standard for plasmin than the IRP in that the former binds to fibrin whereas only 50% of the latter binds. The PIRP compared well to other plasmin preparations and the potency assays were independent of the assay procedure and substrate used. Degradation studies indicated that the PIRP was far more stable than the glycerol solution of the IRP, surviving for 12 months at 37 degrees C with no significant loss in either amidolytic or fibrinolytic activity. The International Committee for Thrombosis and Haemostasis (Bergamo, 1982) has recommended the use of this material as a standard and it has been established by the Expert Committee on Biological Standardization of the World Health Organization as the second International Reference Preparation for Plasmin with a defined potency of 10 International Units of Plasmin per ampoule.
开展了一项涉及七个实验室的国际合作研究,以评估人纤溶酶冻干制剂替代当前纤溶酶国际参考制剂(IRP)的适用性。所有参与实验室均采用发色底物法和纤维蛋白溶解测定法来评估拟议国际参考制剂(PIRP)以及另外两种冻干纤溶酶的效价,其中一种为人源,另一种为猪源。数据表明,与IRP相比,PIRP是更合适的纤溶酶标准品,因为前者可与纤维蛋白结合,而后者只有50%能结合。PIRP与其他纤溶酶制剂相比表现良好,效价测定与所采用的测定方法和底物无关。降解研究表明,PIRP远比IRP的甘油溶液稳定,在37℃下可保存12个月,其酰胺水解或纤维蛋白溶解活性均无显著损失。国际血栓与止血委员会(贝加莫,1982年)已建议使用该物质作为标准品,并且它已被世界卫生组织生物标准化专家委员会确立为第二种纤溶酶国际参考制剂,每安瓿纤溶酶的规定效价为10国际单位。